Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients.

Background/aim: Reports indicate that coronaviridae may inhibit insulin secretion. In this report we aimed to describe the course of glycemia in critically ill patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection.

Patients And Methods: We studied 36 SARS-CoV-2 patients (with no history of diabetes) in one intensive care unit (ICU).